INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio Update as at 28 February 2014
|
Total net assets |
£210.3m |
|
NAV per share |
381.4p |
|
Share price |
330.8p |
|
Total value of unquoted investments |
£26.4m |
|
Total number of portfolio companies |
95 |
Top Ten Holdings
|
Company Name |
% NAV |
|
Biogen |
7.2 |
|
Gilead |
6.9 |
|
Regeneron |
5.9 |
|
Celgene |
5.6 |
|
Alexion |
4.1 |
|
Amgen |
3.8 |
|
Illumina |
3.6 |
|
Vertex |
3.3 |
|
Mylan |
3.1 |
|
Aptiv |
2.3 |
|
|
----------- |
|
Total |
45.8 |
|
Trust Characteristics |
% NAV |
|
Profitable |
62 |
|
Turning Profitable 2015 |
9 |
|
Unprofitable |
29 |
|
|
----------- |
|
Total |
100 |
|
Geographical Allocation |
% NAV |
|
United States & Canada |
92 |
|
Europe & UK |
8 |
|
|
----------- |
|
Total |
100 |
|
Quoted/Unquoted allocation |
% NAV |
|
Quoted |
88 |
|
Unquoted |
12 |
|
|
----------- |
|
Total |
100 |
BNP Paribas Secretarial Services Limited
Company Secretary
20 MARCH 2014